Baxalta Inc Set To Abandon Talks With Ariad Pharmaceuticals, Inc. – ValueWalk Premium

Baxalta Inc Set To Abandon Talks With Ariad Pharmaceuticals, Inc.

According to a report published by Bloomberg this morning, Baxalta Inc. has abandoned its pursuit of Ariad Pharmaceuticals Inc. The report suggests that the deal broke down earlier this week, due to a disagreement over the price Baxalta was willing to pay for its smaller peer.

Shares of Ariad, which develops leukemia and lung cancer treatments, fell as much as 22% in . . .

SORRY!

This content is exclusively for paying members.

If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.


X
Saved Articles
X
TextTExtLInkTextTExtLInk

0